Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study

Figure 5

The impact of miR-607 on the EMT ability of PDAC cells. (a) Western blotting analysis assay confirmed the reduced expression of MMP-2 and MMP-9 (normalized to GAPDH) after miR-607 was overexpressed in BxPc-3 and PANC-1 cells. (b) Relative protein expression levels of EMT-related genes in PDAC cells after miR-607 overexpression were determined. Data were representative of at least three separate experiments.

(a)

(b)